[HTML][HTML] Immune cell-mediated features of non-alcoholic steatohepatitis

T Huby, EL Gautier - Nature reviews immunology, 2022 - nature.com
Non-alcoholic fatty liver disease (NAFLD) includes a range of hepatic manifestations,
starting with liver steatosis and potentially evolving towards non-alcoholic steatohepatitis …

[HTML][HTML] The immune landscape in nonalcoholic steatohepatitis

S Narayanan, FA Surette, YS Hahn - Immune Network, 2016 - synapse.koreamed.org
The liver lies at the intersection of multiple metabolic pathways and consequently plays a
central role in lipid metabolism. Pathological disturbances in hepatic lipid metabolism are …

The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH)

M Nati, D Haddad, AL Birkenfeld, CA Koch… - Reviews in Endocrine …, 2016 - Springer
The low grade inflammatory state present in obesity promotes the progression of Non-
Alcoholic Fatty Liver Disease (NAFLD). In Non-Alcoholic Steatohepatitis (NASH) …

[HTML][HTML] Inflammatory mechanisms underlying nonalcoholic steatohepatitis and the transition to hepatocellular carcinoma

M Peiseler, F Tacke - Cancers, 2021 - mdpi.com
Simple Summary Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver
disease affecting a quarter of the global population and carries the risk of developing …

[HTML][HTML] Emerging roles of T cells in the pathogenesis of nonalcoholic steatohepatitis and hepatocellular carcinoma

P Hirsova, AO Bamidele, H Wang, D Povero… - Frontiers in …, 2021 - frontiersin.org
Nonalcoholic fatty liver disease (NAFLD) has become the most common chronic liver
disease worldwide. A significant proportion of patients with NAFLD develop a progressive …

[PDF][PDF] The role of innate immune cells in nonalcoholic steatohepatitis

J Cai, XJ Zhang, H Li - Hepatology, 2019 - Wiley Online Library
Inflammation and metabolic dysfunction are hallmarks of nonalcoholic steatohepatitis
(NASH), which is one of the fastest‐growing liver diseases worldwide. Emerging evidence …

[HTML][HTML] The role of innate immune cells in nonalcoholic fatty liver disease

M Nati, KJ Chung, T Chavakis - Journal of Innate Immunity, 2022 - karger.com
Nonalcoholic fatty liver disease (NAFLD) is a very common hepatic pathology featuring
steatosis and is linked to obesity and related conditions, such as the metabolic syndrome …

[HTML][HTML] Adaptive immunity: an emerging player in the progression of NAFLD

S Sutti, E Albano - Nature Reviews Gastroenterology & Hepatology, 2020 - nature.com
In the past decade, nonalcoholic fatty liver disease (NAFLD) has become a leading cause of
chronic liver disease and cirrhosis, as well as an important risk factor for hepatocellular …

[HTML][HTML] Chronic inflammation in non-alcoholic steatohepatitis: molecular mechanisms and therapeutic strategies

C Luci, M Bourinet, PS Leclère, R Anty… - Frontiers in …, 2020 - frontiersin.org
Non-Alcoholic Steatohepatitis (NASH) is the progressive form of Non-Alcoholic Fatty Liver
Disease (NAFLD), the main cause of chronic liver complications. The development of NASH …

[HTML][HTML] Hepatic stellate cell-immune interactions in NASH

JK Carter, SL Friedman - Frontiers in Endocrinology, 2022 - frontiersin.org
Nonalcoholic fatty liver disease (NAFLD) is the dominant cause of liver disease worldwide.
Nonalcoholic steatohepatitis (NASH), a more aggressive presentation of NAFLD, is …